CryoPort, Inc. (CYRX) Hits New 12-Month High at $8.54
CryoPort, Inc. (NASDAQ:CYRX) hit a new 52-week high during trading on Wednesday . The stock traded as high as $8.54 and last traded at $8.53, with a volume of 266,052 shares trading hands. The stock had previously closed at $8.08.
CYRX has been the topic of several research analyst reports. Janney Montgomery Scott set a $8.00 target price on CryoPort and gave the company a “buy” rating in a research report on Wednesday, July 26th. Needham & Company LLC upped their target price on CryoPort from $6.00 to $8.50 and gave the company a “buy” rating in a research report on Wednesday, July 26th. ValuEngine upgraded CryoPort from a “sell” rating to a “hold” rating in a research report on Thursday, May 11th. Finally, Cowen and Company upped their target price on CryoPort from $5.50 to $7.50 and gave the company an “outperform” rating in a research report on Wednesday, August 9th.
The company’s 50 day moving average is $6.90 and its 200 day moving average is $4.35. The firm’s market cap is $210.72 million.
CryoPort (NASDAQ:CYRX) last posted its quarterly earnings data on Tuesday, August 8th. The company reported ($0.08) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. The business had revenue of $2.92 million for the quarter, compared to analysts’ expectations of $2.84 million. CryoPort had a negative return on equity of 67.75% and a negative net margin of 102.89%. Equities research analysts forecast that CryoPort, Inc. will post ($0.72) earnings per share for the current year.
Institutional investors have recently bought and sold shares of the business. Taylor Wealth Management Partners bought a new stake in CryoPort during the 2nd quarter valued at approximately $1,851,000. BerganKDV Wealth Management LLC boosted its position in CryoPort by 157.5% during the 2nd quarter. BerganKDV Wealth Management LLC now owns 25,750 shares of the company’s stock valued at $127,000 after acquiring an additional 15,750 shares in the last quarter. EAM Investors LLC bought a new stake in CryoPort during the 2nd quarter valued at approximately $552,000. Vanguard Group Inc. boosted its position in CryoPort by 96.9% during the 2nd quarter. Vanguard Group Inc. now owns 519,100 shares of the company’s stock valued at $2,554,000 after acquiring an additional 255,519 shares in the last quarter. Finally, Northern Trust Corp boosted its position in CryoPort by 105.0% during the 2nd quarter. Northern Trust Corp now owns 22,179 shares of the company’s stock valued at $109,000 after acquiring an additional 11,358 shares in the last quarter. 12.05% of the stock is currently owned by institutional investors and hedge funds.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.